nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—lung cancer	0.0698	0.131	CbGbCtD
Perphenazine—CYP2C19—Gefitinib—lung cancer	0.0301	0.0568	CbGbCtD
Perphenazine—CYP2C19—Teniposide—lung cancer	0.0292	0.055	CbGbCtD
Perphenazine—CYP2B6—Irinotecan—lung cancer	0.0253	0.0477	CbGbCtD
Perphenazine—CYP2C9—Gefitinib—lung cancer	0.0251	0.0472	CbGbCtD
Perphenazine—CYP2C9—Teniposide—lung cancer	0.0243	0.0458	CbGbCtD
Perphenazine—CYP2D6—Gefitinib—lung cancer	0.0229	0.0431	CbGbCtD
Perphenazine—CYP2C8—Erlotinib—lung cancer	0.0212	0.04	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—lung cancer	0.0206	0.0389	CbGbCtD
Perphenazine—CYP2C8—Paclitaxel—lung cancer	0.0194	0.0366	CbGbCtD
Perphenazine—CYP2D6—Vinorelbine—lung cancer	0.0177	0.0332	CbGbCtD
Perphenazine—CYP1A2—Erlotinib—lung cancer	0.0164	0.031	CbGbCtD
Perphenazine—CYP3A4—Topotecan—lung cancer	0.0159	0.03	CbGbCtD
Perphenazine—CYP2C8—Etoposide—lung cancer	0.0154	0.0289	CbGbCtD
Perphenazine—CYP3A4—Gefitinib—lung cancer	0.0146	0.0274	CbGbCtD
Perphenazine—CYP3A4—Teniposide—lung cancer	0.0141	0.0266	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—lung cancer	0.0138	0.0261	CbGbCtD
Perphenazine—CYP2C9—Paclitaxel—lung cancer	0.0136	0.0255	CbGbCtD
Perphenazine—CYP2D6—Erlotinib—lung cancer	0.0135	0.0255	CbGbCtD
Perphenazine—CYP1A2—Etoposide—lung cancer	0.0119	0.0224	CbGbCtD
Perphenazine—CYP3A4—Vinorelbine—lung cancer	0.0112	0.0211	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—lung cancer	0.0109	0.0205	CbGbCtD
Perphenazine—CYP2D6—Vinblastine—lung cancer	0.0109	0.0205	CbGbCtD
Perphenazine—HTR2A—phrenic nerve—lung cancer	0.0105	0.162	CbGeAlD
Perphenazine—CYP3A4—Crizotinib—lung cancer	0.00893	0.0168	CbGbCtD
Perphenazine—CYP3A4—Erlotinib—lung cancer	0.00861	0.0162	CbGbCtD
Perphenazine—CYP3A4—Paclitaxel—lung cancer	0.00789	0.0148	CbGbCtD
Perphenazine—CYP3A4—Irinotecan—lung cancer	0.00778	0.0146	CbGbCtD
Perphenazine—CYP3A4—Vinblastine—lung cancer	0.00692	0.013	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—lung cancer	0.00668	0.0126	CbGbCtD
Perphenazine—CYP3A4—Etoposide—lung cancer	0.00623	0.0117	CbGbCtD
Perphenazine—HTR7—pulmonary artery—lung cancer	0.0061	0.0944	CbGeAlD
Perphenazine—CYP3A4—Docetaxel—lung cancer	0.0057	0.0107	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—lung cancer	0.00425	0.008	CbGbCtD
Perphenazine—HTR2A—pulmonary artery—lung cancer	0.0038	0.0588	CbGeAlD
Perphenazine—CALM3—mammary gland—lung cancer	0.00202	0.0312	CbGeAlD
Perphenazine—CYP2C18—bronchus—lung cancer	0.00194	0.03	CbGeAlD
Perphenazine—CALM1—mammary gland—lung cancer	0.00158	0.0244	CbGeAlD
Perphenazine—CYP2C8—mammary gland—lung cancer	0.00131	0.0203	CbGeAlD
Perphenazine—AOX1—bronchus—lung cancer	0.00123	0.019	CbGeAlD
Perphenazine—CYP2C9—mammary gland—lung cancer	0.00117	0.018	CbGeAlD
Perphenazine—CALM3—bronchus—lung cancer	0.00111	0.0171	CbGeAlD
Perphenazine—AOX1—trachea—lung cancer	0.0011	0.0171	CbGeAlD
Perphenazine—CALM2—respiratory system—lung cancer	0.00105	0.0163	CbGeAlD
Perphenazine—CALM1—respiratory system—lung cancer	0.00105	0.0162	CbGeAlD
Perphenazine—AOX1—cardiac atrium—lung cancer	0.00104	0.016	CbGeAlD
Perphenazine—HTR7—respiratory system—lung cancer	0.00103	0.0159	CbGeAlD
Perphenazine—CALM3—trachea—lung cancer	0.000993	0.0154	CbGeAlD
Perphenazine—DRD2—respiratory system—lung cancer	0.00097	0.015	CbGeAlD
Perphenazine—CALM3—cardiac atrium—lung cancer	0.000933	0.0144	CbGeAlD
Perphenazine—CALM2—epithelium—lung cancer	0.000882	0.0136	CbGeAlD
Perphenazine—CALM1—epithelium—lung cancer	0.000878	0.0136	CbGeAlD
Perphenazine—CALM2—bronchus—lung cancer	0.000868	0.0134	CbGeAlD
Perphenazine—CALM1—bronchus—lung cancer	0.000864	0.0134	CbGeAlD
Perphenazine—HTR7—epithelium—lung cancer	0.000857	0.0133	CbGeAlD
Perphenazine—CYP1A2—respiratory system—lung cancer	0.000818	0.0127	CbGeAlD
Perphenazine—AOX1—lung—lung cancer	0.000792	0.0123	CbGeAlD
Perphenazine—CALM3—bone marrow—lung cancer	0.000787	0.0122	CbGeAlD
Perphenazine—CYP2B6—respiratory system—lung cancer	0.000784	0.0121	CbGeAlD
Perphenazine—CALM2—trachea—lung cancer	0.00078	0.0121	CbGeAlD
Perphenazine—CALM1—trachea—lung cancer	0.000776	0.012	CbGeAlD
Perphenazine—HRH1—respiratory system—lung cancer	0.000766	0.0119	CbGeAlD
Perphenazine—HTR7—trachea—lung cancer	0.000758	0.0117	CbGeAlD
Perphenazine—CALM2—cardiac atrium—lung cancer	0.000732	0.0113	CbGeAlD
Perphenazine—CALM1—cardiac atrium—lung cancer	0.000729	0.0113	CbGeAlD
Perphenazine—CALM3—lung—lung cancer	0.000713	0.011	CbGeAlD
Perphenazine—CYP2B6—bronchus—lung cancer	0.000645	0.00999	CbGeAlD
Perphenazine—HRH1—epithelium—lung cancer	0.00064	0.0099	CbGeAlD
Perphenazine—HTR2A—respiratory system—lung cancer	0.00064	0.0099	CbGeAlD
Perphenazine—ADRA2A—bronchus—lung cancer	0.000619	0.00958	CbGeAlD
Perphenazine—CALM2—bone marrow—lung cancer	0.000618	0.00957	CbGeAlD
Perphenazine—CALM1—bone marrow—lung cancer	0.000615	0.00952	CbGeAlD
Perphenazine—HRH1—trachea—lung cancer	0.000566	0.00876	CbGeAlD
Perphenazine—CALM2—lung—lung cancer	0.00056	0.00867	CbGeAlD
Perphenazine—CALM1—lung—lung cancer	0.000558	0.00863	CbGeAlD
Perphenazine—ADRA2A—trachea—lung cancer	0.000556	0.0086	CbGeAlD
Perphenazine—HTR7—lung—lung cancer	0.000545	0.00843	CbGeAlD
Perphenazine—AOX1—lymph node—lung cancer	0.000542	0.00838	CbGeAlD
Perphenazine—HTR2A—epithelium—lung cancer	0.000535	0.00827	CbGeAlD
Perphenazine—ADRA2A—cardiac atrium—lung cancer	0.000522	0.00808	CbGeAlD
Perphenazine—DRD2—lung—lung cancer	0.000515	0.00797	CbGeAlD
Perphenazine—CALM3—lymph node—lung cancer	0.000488	0.00755	CbGeAlD
Perphenazine—HTR2A—trachea—lung cancer	0.000473	0.00732	CbGeAlD
Perphenazine—CYP1A2—lung—lung cancer	0.000434	0.00672	CbGeAlD
Perphenazine—CYP2B6—lung—lung cancer	0.000416	0.00644	CbGeAlD
Perphenazine—HRH1—lung—lung cancer	0.000407	0.00629	CbGeAlD
Perphenazine—ADRA2A—lung—lung cancer	0.000399	0.00618	CbGeAlD
Perphenazine—CALM2—lymph node—lung cancer	0.000383	0.00593	CbGeAlD
Perphenazine—CALM1—lymph node—lung cancer	0.000381	0.0059	CbGeAlD
Perphenazine—HTR2A—lung—lung cancer	0.00034	0.00526	CbGeAlD
Perphenazine—Clomipramine—GSTP1—lung cancer	0.000309	0.109	CrCbGaD
Perphenazine—HRH1—lymph node—lung cancer	0.000278	0.0043	CbGeAlD
Perphenazine—ADRA2A—lymph node—lung cancer	0.000273	0.00423	CbGeAlD
Perphenazine—Leukopenia—Irinotecan—lung cancer	0.000252	0.00144	CcSEcCtD
Perphenazine—Dyspnoea—Vinorelbine—lung cancer	0.000248	0.00142	CcSEcCtD
Perphenazine—Loss of consciousness—Irinotecan—lung cancer	0.000248	0.00142	CcSEcCtD
Perphenazine—Hypersensitivity—Vinblastine—lung cancer	0.000247	0.00141	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000247	0.00141	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—lung cancer	0.000246	0.00141	CcSEcCtD
Perphenazine—Cough—Irinotecan—lung cancer	0.000246	0.00141	CcSEcCtD
Perphenazine—Leukopenia—Gemcitabine—lung cancer	0.000246	0.00141	CcSEcCtD
Perphenazine—Hypertension—Irinotecan—lung cancer	0.000243	0.00139	CcSEcCtD
Perphenazine—Jaundice—Docetaxel—lung cancer	0.000243	0.00139	CcSEcCtD
Perphenazine—Decreased appetite—Vinorelbine—lung cancer	0.000242	0.00139	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—lung cancer	0.000241	0.00138	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000241	0.00138	CcSEcCtD
Perphenazine—Hypersensitivity—Topotecan—lung cancer	0.00024	0.00137	CcSEcCtD
Perphenazine—Cough—Gemcitabine—lung cancer	0.000239	0.00137	CcSEcCtD
Perphenazine—Constipation—Vinorelbine—lung cancer	0.000238	0.00136	CcSEcCtD
Perphenazine—Pain—Vinorelbine—lung cancer	0.000238	0.00136	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—lung cancer	0.000238	0.00136	CcSEcCtD
Perphenazine—Hypertension—Gemcitabine—lung cancer	0.000237	0.00136	CcSEcCtD
Perphenazine—Agranulocytosis—Docetaxel—lung cancer	0.000232	0.00133	CcSEcCtD
Perphenazine—Confusional state—Irinotecan—lung cancer	0.000232	0.00133	CcSEcCtD
Perphenazine—Pruritus—Topotecan—lung cancer	0.00023	0.00132	CcSEcCtD
Perphenazine—Anaphylactic shock—Irinotecan—lung cancer	0.00023	0.00132	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—lung cancer	0.00023	0.00131	CcSEcCtD
Perphenazine—Erythema—Paclitaxel—lung cancer	0.00023	0.00131	CcSEcCtD
Perphenazine—Diarrhoea—Vinblastine—lung cancer	0.000229	0.00131	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—lung cancer	0.000229	0.00131	CcSEcCtD
Perphenazine—Infection—Irinotecan—lung cancer	0.000228	0.00131	CcSEcCtD
Perphenazine—Pruritus—Erlotinib—lung cancer	0.000228	0.0013	CcSEcCtD
Perphenazine—Shock—Irinotecan—lung cancer	0.000226	0.00129	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—lung cancer	0.000225	0.00129	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—lung cancer	0.000224	0.00128	CcSEcCtD
Perphenazine—Anaphylactic shock—Gemcitabine—lung cancer	0.000224	0.00128	CcSEcCtD
Perphenazine—Diarrhoea—Topotecan—lung cancer	0.000223	0.00128	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—lung cancer	0.000222	0.00127	CcSEcCtD
Perphenazine—Infection—Gemcitabine—lung cancer	0.000222	0.00127	CcSEcCtD
Perphenazine—Dizziness—Vinblastine—lung cancer	0.000222	0.00127	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—lung cancer	0.000222	0.00127	CcSEcCtD
Perphenazine—Urticaria—Vinorelbine—lung cancer	0.000221	0.00127	CcSEcCtD
Perphenazine—Muscle spasms—Paclitaxel—lung cancer	0.000221	0.00126	CcSEcCtD
Perphenazine—Diarrhoea—Erlotinib—lung cancer	0.000221	0.00126	CcSEcCtD
Perphenazine—Body temperature increased—Vinorelbine—lung cancer	0.00022	0.00126	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—lung cancer	0.00022	0.00126	CcSEcCtD
Perphenazine—Anorexia—Irinotecan—lung cancer	0.000219	0.00125	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—lung cancer	0.000219	0.00125	CcSEcCtD
Perphenazine—Flupentixol—ABCB1—lung cancer	0.000217	0.0766	CrCbGaD
Perphenazine—Vision blurred—Paclitaxel—lung cancer	0.000216	0.00124	CcSEcCtD
Perphenazine—Dizziness—Topotecan—lung cancer	0.000215	0.00123	CcSEcCtD
Perphenazine—Hypotension—Irinotecan—lung cancer	0.000215	0.00123	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000214	0.00122	CcSEcCtD
Perphenazine—Anorexia—Gemcitabine—lung cancer	0.000213	0.00122	CcSEcCtD
Perphenazine—Dizziness—Erlotinib—lung cancer	0.000213	0.00122	CcSEcCtD
Perphenazine—Agitation—Paclitaxel—lung cancer	0.000211	0.00121	CcSEcCtD
Perphenazine—Headache—Vinblastine—lung cancer	0.00021	0.0012	CcSEcCtD
Perphenazine—Angioedema—Paclitaxel—lung cancer	0.00021	0.0012	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—lung cancer	0.00021	0.0012	CcSEcCtD
Perphenazine—Hypotension—Gemcitabine—lung cancer	0.000209	0.0012	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—lung cancer	0.000209	0.00119	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000208	0.00119	CcSEcCtD
Perphenazine—Insomnia—Irinotecan—lung cancer	0.000208	0.00119	CcSEcCtD
Perphenazine—Infection—Cisplatin—lung cancer	0.000207	0.00119	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—lung cancer	0.000207	0.00118	CcSEcCtD
Perphenazine—Syncope—Paclitaxel—lung cancer	0.000206	0.00118	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—lung cancer	0.000206	0.00118	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—lung cancer	0.000206	0.00118	CcSEcCtD
Perphenazine—Leukopenia—Paclitaxel—lung cancer	0.000206	0.00118	CcSEcCtD
Perphenazine—Hypersensitivity—Vinorelbine—lung cancer	0.000205	0.00117	CcSEcCtD
Perphenazine—Dyspnoea—Irinotecan—lung cancer	0.000205	0.00117	CcSEcCtD
Perphenazine—Cough—Etoposide—lung cancer	0.000204	0.00117	CcSEcCtD
Perphenazine—Somnolence—Irinotecan—lung cancer	0.000204	0.00117	CcSEcCtD
Perphenazine—Headache—Topotecan—lung cancer	0.000204	0.00117	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—lung cancer	0.000204	0.00117	CcSEcCtD
Perphenazine—Convulsion—Etoposide—lung cancer	0.000203	0.00116	CcSEcCtD
Perphenazine—Insomnia—Gemcitabine—lung cancer	0.000202	0.00116	CcSEcCtD
Perphenazine—Hypertension—Etoposide—lung cancer	0.000202	0.00116	CcSEcCtD
Perphenazine—Headache—Erlotinib—lung cancer	0.000202	0.00116	CcSEcCtD
Perphenazine—Loss of consciousness—Paclitaxel—lung cancer	0.000202	0.00116	CcSEcCtD
Perphenazine—Asthma—Methotrexate—lung cancer	0.000201	0.00115	CcSEcCtD
Perphenazine—Cough—Paclitaxel—lung cancer	0.0002	0.00115	CcSEcCtD
Perphenazine—Decreased appetite—Irinotecan—lung cancer	0.0002	0.00114	CcSEcCtD
Perphenazine—Dyspnoea—Gemcitabine—lung cancer	0.0002	0.00114	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—lung cancer	0.000199	0.00114	CcSEcCtD
Perphenazine—Somnolence—Gemcitabine—lung cancer	0.000199	0.00114	CcSEcCtD
Perphenazine—Convulsion—Paclitaxel—lung cancer	0.000199	0.00114	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—lung cancer	0.000199	0.00114	CcSEcCtD
Perphenazine—Hypertension—Paclitaxel—lung cancer	0.000198	0.00113	CcSEcCtD
Perphenazine—Pruritus—Vinorelbine—lung cancer	0.000197	0.00113	CcSEcCtD
Perphenazine—Pain—Irinotecan—lung cancer	0.000197	0.00112	CcSEcCtD
Perphenazine—Constipation—Irinotecan—lung cancer	0.000197	0.00112	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—lung cancer	0.000195	0.00112	CcSEcCtD
Perphenazine—Erythema—Docetaxel—lung cancer	0.000195	0.00111	CcSEcCtD
Perphenazine—Decreased appetite—Gemcitabine—lung cancer	0.000195	0.00111	CcSEcCtD
Perphenazine—Confusional state—Etoposide—lung cancer	0.000193	0.0011	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—lung cancer	0.000192	0.0011	CcSEcCtD
Perphenazine—Pain—Gemcitabine—lung cancer	0.000191	0.0011	CcSEcCtD
Perphenazine—Constipation—Gemcitabine—lung cancer	0.000191	0.0011	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—lung cancer	0.000191	0.00109	CcSEcCtD
Perphenazine—Dry mouth—Paclitaxel—lung cancer	0.000191	0.00109	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—lung cancer	0.000191	0.00109	CcSEcCtD
Perphenazine—Diarrhoea—Vinorelbine—lung cancer	0.000191	0.00109	CcSEcCtD
Perphenazine—Infection—Etoposide—lung cancer	0.00019	0.00109	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—lung cancer	0.00019	0.00109	CcSEcCtD
Perphenazine—Confusional state—Paclitaxel—lung cancer	0.000189	0.00108	CcSEcCtD
Perphenazine—Anaphylactic shock—Paclitaxel—lung cancer	0.000187	0.00107	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—lung cancer	0.000187	0.00107	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—lung cancer	0.000187	0.00107	CcSEcCtD
Perphenazine—Infection—Paclitaxel—lung cancer	0.000186	0.00107	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—lung cancer	0.000186	0.00106	CcSEcCtD
Perphenazine—Shock—Paclitaxel—lung cancer	0.000184	0.00106	CcSEcCtD
Perphenazine—Dizziness—Vinorelbine—lung cancer	0.000184	0.00105	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000184	0.00105	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000184	0.00105	CcSEcCtD
Perphenazine—Tachycardia—Paclitaxel—lung cancer	0.000183	0.00105	CcSEcCtD
Perphenazine—Anorexia—Etoposide—lung cancer	0.000182	0.00104	CcSEcCtD
Perphenazine—Body temperature increased—Irinotecan—lung cancer	0.000182	0.00104	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—lung cancer	0.000181	0.00104	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—lung cancer	0.00018	0.00103	CcSEcCtD
Perphenazine—Anorexia—Paclitaxel—lung cancer	0.000179	0.00102	CcSEcCtD
Perphenazine—Hypotension—Etoposide—lung cancer	0.000179	0.00102	CcSEcCtD
Perphenazine—Pain—Cisplatin—lung cancer	0.000178	0.00102	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—lung cancer	0.000178	0.00102	CcSEcCtD
Perphenazine—Body temperature increased—Gemcitabine—lung cancer	0.000177	0.00101	CcSEcCtD
Perphenazine—Hypotension—Paclitaxel—lung cancer	0.000175	0.001	CcSEcCtD
Perphenazine—Headache—Vinorelbine—lung cancer	0.000175	0.000999	CcSEcCtD
Perphenazine—Syncope—Docetaxel—lung cancer	0.000175	0.000999	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—lung cancer	0.000174	0.000998	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—lung cancer	0.000174	0.000998	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—lung cancer	0.000174	0.000997	CcSEcCtD
Perphenazine—Fluphenazine—CYP2E1—lung cancer	0.000174	0.0612	CrCbGaD
Perphenazine—Eosinophilia—Doxorubicin—lung cancer	0.000173	0.000988	CcSEcCtD
Perphenazine—Loss of consciousness—Docetaxel—lung cancer	0.000171	0.000979	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—lung cancer	0.00017	0.000975	CcSEcCtD
Perphenazine—Somnolence—Etoposide—lung cancer	0.00017	0.000973	CcSEcCtD
Perphenazine—Cough—Docetaxel—lung cancer	0.00017	0.000972	CcSEcCtD
Perphenazine—Insomnia—Paclitaxel—lung cancer	0.00017	0.00097	CcSEcCtD
Perphenazine—Hypersensitivity—Irinotecan—lung cancer	0.000169	0.000969	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—lung cancer	0.000169	0.000965	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—lung cancer	0.000168	0.000962	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—lung cancer	0.000168	0.000959	CcSEcCtD
Perphenazine—Dyspnoea—Paclitaxel—lung cancer	0.000167	0.000956	CcSEcCtD
Perphenazine—Somnolence—Paclitaxel—lung cancer	0.000167	0.000954	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—lung cancer	0.000166	0.000951	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—lung cancer	0.000166	0.000948	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—lung cancer	0.000165	0.000944	CcSEcCtD
Perphenazine—Pain—Etoposide—lung cancer	0.000163	0.000936	CcSEcCtD
Perphenazine—Constipation—Etoposide—lung cancer	0.000163	0.000936	CcSEcCtD
Perphenazine—Decreased appetite—Paclitaxel—lung cancer	0.000163	0.000932	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—lung cancer	0.000162	0.000928	CcSEcCtD
Perphenazine—Constipation—Paclitaxel—lung cancer	0.00016	0.000917	CcSEcCtD
Perphenazine—Pain—Paclitaxel—lung cancer	0.00016	0.000917	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—lung cancer	0.00016	0.000917	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000159	0.000911	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—lung cancer	0.000159	0.000909	CcSEcCtD
Perphenazine—Pruritus—Gemcitabine—lung cancer	0.000158	0.000906	CcSEcCtD
Perphenazine—Infection—Docetaxel—lung cancer	0.000158	0.000903	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—lung cancer	0.000157	0.0009	CcSEcCtD
Perphenazine—Diarrhoea—Irinotecan—lung cancer	0.000157	0.0009	CcSEcCtD
Perphenazine—Shock—Docetaxel—lung cancer	0.000156	0.000894	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—lung cancer	0.000155	0.00089	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—lung cancer	0.000155	0.000887	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—lung cancer	0.000154	0.00088	CcSEcCtD
Perphenazine—Diarrhoea—Gemcitabine—lung cancer	0.000153	0.000877	CcSEcCtD
Perphenazine—Dizziness—Irinotecan—lung cancer	0.000152	0.00087	CcSEcCtD
Perphenazine—Urticaria—Etoposide—lung cancer	0.000152	0.000869	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—lung cancer	0.000152	0.000867	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—lung cancer	0.000151	0.000867	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—lung cancer	0.000151	0.000865	CcSEcCtD
Perphenazine—Thioridazine—CYP2E1—lung cancer	0.00015	0.0527	CrCbGaD
Perphenazine—Urticaria—Paclitaxel—lung cancer	0.000149	0.000852	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—lung cancer	0.000148	0.00085	CcSEcCtD
Perphenazine—Body temperature increased—Paclitaxel—lung cancer	0.000148	0.000848	CcSEcCtD
Perphenazine—Domperidone—ABCB1—lung cancer	0.000146	0.0515	CrCbGaD
Perphenazine—Agranulocytosis—Doxorubicin—lung cancer	0.000145	0.00083	CcSEcCtD
Perphenazine—Headache—Irinotecan—lung cancer	0.000144	0.000824	CcSEcCtD
Perphenazine—Insomnia—Docetaxel—lung cancer	0.000144	0.000822	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—lung cancer	0.000143	0.000817	CcSEcCtD
Perphenazine—Methotrimeprazine—CYP2E1—lung cancer	0.000143	0.0503	CrCbGaD
Perphenazine—Bradycardia—Doxorubicin—lung cancer	0.000142	0.000813	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—lung cancer	0.000142	0.000811	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—lung cancer	0.000141	0.000808	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—lung cancer	0.000141	0.000806	CcSEcCtD
Perphenazine—Erythema—Methotrexate—lung cancer	0.00014	0.000803	CcSEcCtD
Perphenazine—Headache—Gemcitabine—lung cancer	0.00014	0.000803	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—lung cancer	0.000139	0.000795	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—lung cancer	0.000138	0.00079	CcSEcCtD
Perphenazine—Hypersensitivity—Paclitaxel—lung cancer	0.000138	0.00079	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—lung cancer	0.000137	0.000787	CcSEcCtD
Perphenazine—Pain—Docetaxel—lung cancer	0.000136	0.000777	CcSEcCtD
Perphenazine—Constipation—Docetaxel—lung cancer	0.000136	0.000777	CcSEcCtD
Perphenazine—Pruritus—Etoposide—lung cancer	0.000135	0.000774	CcSEcCtD
Perphenazine—Pruritus—Paclitaxel—lung cancer	0.000133	0.000759	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—lung cancer	0.000132	0.000757	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—lung cancer	0.000131	0.000749	CcSEcCtD
Perphenazine—Diarrhoea—Paclitaxel—lung cancer	0.000128	0.000734	CcSEcCtD
Perphenazine—Dizziness—Etoposide—lung cancer	0.000126	0.000723	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—lung cancer	0.000126	0.000719	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—lung cancer	0.000126	0.000719	CcSEcCtD
Perphenazine—Dizziness—Paclitaxel—lung cancer	0.000124	0.000709	CcSEcCtD
Perphenazine—Cough—Methotrexate—lung cancer	0.000122	0.000701	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—lung cancer	0.000122	0.000696	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—lung cancer	0.000121	0.000695	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—lung cancer	0.000121	0.0428	CrCbGaD
Perphenazine—Headache—Etoposide—lung cancer	0.00012	0.000685	CcSEcCtD
Perphenazine—Triflupromazine—ABCB1—lung cancer	0.000118	0.0417	CrCbGaD
Perphenazine—Headache—Paclitaxel—lung cancer	0.000117	0.000672	CcSEcCtD
Perphenazine—Hypersensitivity—Docetaxel—lung cancer	0.000117	0.00067	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—lung cancer	0.000117	0.000668	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—lung cancer	0.000115	0.000661	CcSEcCtD
Perphenazine—Acepromazine—ALB—lung cancer	0.000115	0.0404	CrCbGaD
Perphenazine—Anaphylactic shock—Methotrexate—lung cancer	0.000115	0.000655	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—lung cancer	0.000114	0.000655	CcSEcCtD
Perphenazine—Infection—Methotrexate—lung cancer	0.000114	0.000651	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—lung cancer	0.000113	0.0398	CrCbGaD
Perphenazine—Pruritus—Docetaxel—lung cancer	0.000112	0.000643	CcSEcCtD
Perphenazine—Trazodone—ABCB1—lung cancer	0.000112	0.0396	CrCbGaD
Perphenazine—Thioproperazine—ALB—lung cancer	0.000112	0.0395	CrCbGaD
Perphenazine—Agitation—Doxorubicin—lung cancer	0.000112	0.000639	CcSEcCtD
Perphenazine—Thiothixene—ALB—lung cancer	0.00011	0.0389	CrCbGaD
Perphenazine—Pipotiazine—ALB—lung cancer	0.00011	0.0389	CrCbGaD
Perphenazine—Anorexia—Methotrexate—lung cancer	0.000109	0.000625	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—lung cancer	0.000109	0.000623	CcSEcCtD
Perphenazine—Chlorpromazine—CYP2E1—lung cancer	0.000109	0.0384	CrCbGaD
Perphenazine—Leukopenia—Doxorubicin—lung cancer	0.000109	0.000622	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—lung cancer	0.000109	0.000622	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—lung cancer	0.000107	0.000612	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—lung cancer	0.000107	0.000611	CcSEcCtD
Perphenazine—Cough—Doxorubicin—lung cancer	0.000106	0.000607	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—lung cancer	0.000105	0.000602	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—lung cancer	0.000105	0.000601	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—lung cancer	0.000105	0.0006	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—lung cancer	0.000104	0.000593	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—lung cancer	0.000102	0.000584	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—lung cancer	0.000102	0.000583	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—lung cancer	0.000101	0.000579	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—lung cancer	0.0001	0.000572	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—lung cancer	9.95e-05	0.00057	CcSEcCtD
Perphenazine—Headache—Docetaxel—lung cancer	9.95e-05	0.00057	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—lung cancer	9.92e-05	0.000567	CcSEcCtD
Perphenazine—Infection—Doxorubicin—lung cancer	9.85e-05	0.000564	CcSEcCtD
Perphenazine—Pain—Methotrexate—lung cancer	9.79e-05	0.00056	CcSEcCtD
Perphenazine—Shock—Doxorubicin—lung cancer	9.75e-05	0.000558	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—lung cancer	9.68e-05	0.000554	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—lung cancer	9.45e-05	0.000541	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—lung cancer	9.26e-05	0.00053	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—lung cancer	9.1e-05	0.0321	CrCbGaD
Perphenazine—Urticaria—Methotrexate—lung cancer	9.1e-05	0.000521	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—lung cancer	9.05e-05	0.000518	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—lung cancer	8.97e-05	0.000513	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—lung cancer	8.84e-05	0.000506	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—lung cancer	8.81e-05	0.000504	CcSEcCtD
Perphenazine—Clomipramine—ALB—lung cancer	8.72e-05	0.0307	CrCbGaD
Perphenazine—Decreased appetite—Doxorubicin—lung cancer	8.62e-05	0.000493	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—lung cancer	8.48e-05	0.000485	CcSEcCtD
Perphenazine—Pain—Doxorubicin—lung cancer	8.48e-05	0.000485	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—lung cancer	8.44e-05	0.000483	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—lung cancer	8.32e-05	0.0293	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—lung cancer	8.29e-05	0.0292	CrCbGaD
Perphenazine—Pruritus—Methotrexate—lung cancer	8.1e-05	0.000464	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—lung cancer	7.88e-05	0.000451	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—lung cancer	7.84e-05	0.000449	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—lung cancer	7.83e-05	0.000448	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—lung cancer	7.57e-05	0.000433	CcSEcCtD
Perphenazine—Promethazine—ABCB1—lung cancer	7.37e-05	0.026	CrCbGaD
Perphenazine—Hypersensitivity—Doxorubicin—lung cancer	7.31e-05	0.000418	CcSEcCtD
Perphenazine—Trifluoperazine—ABCB1—lung cancer	7.27e-05	0.0256	CrCbGaD
Perphenazine—Headache—Methotrexate—lung cancer	7.17e-05	0.000411	CcSEcCtD
Perphenazine—Quetiapine—ABCB1—lung cancer	7.06e-05	0.0249	CrCbGaD
Perphenazine—Pruritus—Doxorubicin—lung cancer	7.01e-05	0.000401	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—lung cancer	6.78e-05	0.000388	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—lung cancer	6.56e-05	0.000375	CcSEcCtD
Perphenazine—Headache—Doxorubicin—lung cancer	6.21e-05	0.000355	CcSEcCtD
Perphenazine—Chlorpromazine—ALB—lung cancer	5.98e-05	0.0211	CrCbGaD
Perphenazine—Chlorpromazine—ABCB1—lung cancer	5.71e-05	0.0201	CrCbGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—lung cancer	2.71e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—lung cancer	2.71e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.71e-06	1.19e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—lung cancer	2.71e-06	1.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—lung cancer	2.71e-06	1.19e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—lung cancer	2.69e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—lung cancer	2.68e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—lung cancer	2.68e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—lung cancer	2.68e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MTOR—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MTOR—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—lung cancer	2.67e-06	1.18e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—lung cancer	2.66e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—lung cancer	2.66e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—lung cancer	2.65e-06	1.17e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—lung cancer	2.64e-06	1.17e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—lung cancer	2.64e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—lung cancer	2.64e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—lung cancer	2.64e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—lung cancer	2.64e-06	1.16e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.63e-06	1.16e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.62e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—lung cancer	2.62e-06	1.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.62e-06	1.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—lung cancer	2.62e-06	1.15e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.61e-06	1.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—lung cancer	2.61e-06	1.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—lung cancer	2.61e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.6e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—lung cancer	2.59e-06	1.14e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—lung cancer	2.59e-06	1.14e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—lung cancer	2.59e-06	1.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.57e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—lung cancer	2.56e-06	1.13e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—lung cancer	2.56e-06	1.13e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.55e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—lung cancer	2.55e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—lung cancer	2.55e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ERCC2—lung cancer	2.55e-06	1.12e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—lung cancer	2.54e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—lung cancer	2.54e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—lung cancer	2.54e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—lung cancer	2.54e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—lung cancer	2.53e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—lung cancer	2.53e-06	1.12e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—lung cancer	2.53e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—lung cancer	2.53e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—lung cancer	2.52e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—lung cancer	2.52e-06	1.11e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—lung cancer	2.5e-06	1.1e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—lung cancer	2.5e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—lung cancer	2.48e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—POMC—lung cancer	2.48e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—lung cancer	2.47e-06	1.09e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—lung cancer	2.47e-06	1.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—lung cancer	2.46e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—lung cancer	2.46e-06	1.08e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.46e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—lung cancer	2.46e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—lung cancer	2.46e-06	1.08e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—lung cancer	2.45e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—lung cancer	2.44e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—lung cancer	2.44e-06	1.08e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—lung cancer	2.43e-06	1.07e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—lung cancer	2.43e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CREBBP—lung cancer	2.42e-06	1.07e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—lung cancer	2.42e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—lung cancer	2.41e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—lung cancer	2.41e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—lung cancer	2.4e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—lung cancer	2.39e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—lung cancer	2.39e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—lung cancer	2.39e-06	1.06e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—lung cancer	2.39e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—lung cancer	2.39e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—lung cancer	2.39e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—lung cancer	2.39e-06	1.05e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—lung cancer	2.39e-06	1.05e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—lung cancer	2.38e-06	1.05e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—lung cancer	2.37e-06	1.05e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.36e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—lung cancer	2.36e-06	1.04e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.35e-06	1.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.34e-06	1.03e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—lung cancer	2.33e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—lung cancer	2.32e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—lung cancer	2.32e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—lung cancer	2.32e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—lung cancer	2.32e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—lung cancer	2.32e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—lung cancer	2.31e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—lung cancer	2.31e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—lung cancer	2.31e-06	1.02e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—lung cancer	2.29e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—lung cancer	2.28e-06	1e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—lung cancer	2.27e-06	1e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—lung cancer	2.26e-06	9.99e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—lung cancer	2.26e-06	9.97e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—lung cancer	2.25e-06	9.94e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—lung cancer	2.25e-06	9.94e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—lung cancer	2.25e-06	9.9e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.24e-06	9.86e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—lung cancer	2.23e-06	9.84e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—lung cancer	2.23e-06	9.84e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—lung cancer	2.23e-06	9.84e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—lung cancer	2.23e-06	9.82e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—lung cancer	2.22e-06	9.78e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—lung cancer	2.21e-06	9.77e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—lung cancer	2.21e-06	9.74e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—lung cancer	2.21e-06	9.74e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOA1—lung cancer	2.21e-06	9.73e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—lung cancer	2.2e-06	9.72e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—lung cancer	2.2e-06	9.72e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—lung cancer	2.2e-06	9.72e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—lung cancer	2.18e-06	9.59e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—lung cancer	2.17e-06	9.59e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—lung cancer	2.16e-06	9.54e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—lung cancer	2.16e-06	9.51e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—lung cancer	2.15e-06	9.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—lung cancer	2.15e-06	9.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—lung cancer	2.14e-06	9.45e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—lung cancer	2.14e-06	9.45e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—lung cancer	2.14e-06	9.42e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—lung cancer	2.13e-06	9.4e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—lung cancer	2.13e-06	9.4e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—lung cancer	2.13e-06	9.39e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.13e-06	9.38e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—lung cancer	2.12e-06	9.33e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—lung cancer	2.09e-06	9.2e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—lung cancer	2.09e-06	9.2e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—lung cancer	2.08e-06	9.18e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—lung cancer	2.07e-06	9.13e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—lung cancer	2.07e-06	9.13e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—lung cancer	2.07e-06	9.11e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—lung cancer	2.07e-06	9.11e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.06e-06	9.1e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—lung cancer	2.06e-06	9.09e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—lung cancer	2.06e-06	9.09e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—lung cancer	2.06e-06	9.09e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—lung cancer	2.06e-06	9.09e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—lung cancer	2.06e-06	9.08e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—lung cancer	2.06e-06	9.08e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—lung cancer	2.04e-06	9e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—lung cancer	2.04e-06	9e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.03e-06	8.95e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	2.03e-06	8.93e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—lung cancer	2.02e-06	8.92e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—lung cancer	2.02e-06	8.89e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.01e-06	8.88e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.01e-06	8.86e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—lung cancer	2e-06	8.82e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—lung cancer	2e-06	8.8e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—lung cancer	1.98e-06	8.75e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—lung cancer	1.98e-06	8.74e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—lung cancer	1.97e-06	8.71e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—lung cancer	1.97e-06	8.71e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—lung cancer	1.97e-06	8.67e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—lung cancer	1.96e-06	8.66e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—lung cancer	1.96e-06	8.64e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—lung cancer	1.95e-06	8.6e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—lung cancer	1.95e-06	8.6e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—lung cancer	1.95e-06	8.58e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—lung cancer	1.94e-06	8.56e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—lung cancer	1.93e-06	8.51e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—lung cancer	1.92e-06	8.47e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—lung cancer	1.92e-06	8.47e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.92e-06	8.46e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—POMC—lung cancer	1.92e-06	8.46e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.91e-06	8.42e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—lung cancer	1.91e-06	8.42e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—lung cancer	1.9e-06	8.39e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—lung cancer	1.9e-06	8.39e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—lung cancer	1.88e-06	8.28e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—lung cancer	1.88e-06	8.28e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.88e-06	8.28e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—lung cancer	1.87e-06	8.26e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CREBBP—lung cancer	1.87e-06	8.24e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.85e-06	8.14e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—lung cancer	1.83e-06	8.09e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—lung cancer	1.83e-06	8.06e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—lung cancer	1.8e-06	7.96e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—lung cancer	1.8e-06	7.93e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—lung cancer	1.79e-06	7.91e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.79e-06	7.88e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—lung cancer	1.77e-06	7.82e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—lung cancer	1.77e-06	7.82e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.77e-06	7.81e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—lung cancer	1.75e-06	7.73e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—lung cancer	1.75e-06	7.71e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—lung cancer	1.73e-06	7.62e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.71e-06	7.53e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—lung cancer	1.69e-06	7.46e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—lung cancer	1.69e-06	7.43e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—lung cancer	1.68e-06	7.43e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—lung cancer	1.66e-06	7.31e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—lung cancer	1.65e-06	7.3e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—lung cancer	1.65e-06	7.27e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—lung cancer	1.65e-06	7.26e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.64e-06	7.21e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—lung cancer	1.63e-06	7.19e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—lung cancer	1.63e-06	7.19e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—lung cancer	1.63e-06	7.19e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—lung cancer	1.59e-06	7.02e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—lung cancer	1.59e-06	7.02e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—lung cancer	1.58e-06	6.95e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—lung cancer	1.58e-06	6.95e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.56e-06	6.9e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—lung cancer	1.56e-06	6.87e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.54e-06	6.81e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—lung cancer	1.53e-06	6.74e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.51e-06	6.65e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—lung cancer	1.51e-06	6.65e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—lung cancer	1.51e-06	6.65e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—lung cancer	1.49e-06	6.58e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—lung cancer	1.44e-06	6.36e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—lung cancer	1.44e-06	6.36e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.44e-06	6.35e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—lung cancer	1.43e-06	6.32e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.43e-06	6.29e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—lung cancer	1.38e-06	6.07e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—lung cancer	1.33e-06	5.88e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—lung cancer	1.33e-06	5.87e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—lung cancer	1.33e-06	5.87e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—lung cancer	1.28e-06	5.64e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—lung cancer	1.27e-06	5.61e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.22e-06	5.38e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—lung cancer	1.18e-06	5.18e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—lung cancer	1.17e-06	5.14e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—lung cancer	9.96e-07	4.39e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—lung cancer	9.41e-07	4.15e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—lung cancer	7.69e-07	3.39e-06	CbGpPWpGaD
